Jason P. Rhodes

2013

In 2013, Jason P. Rhodes earned a total compensation of $3.2M as President and Chief Financial Officer at Epizyme, a 533% increase compared to previous year.

Compensation breakdown

Bonus$149,166
Option Awards$2,658,467
Salary$364,026
Other$1,467
Total$3,173,126

Rhodes received $2.7M in option awards, accounting for 84% of the total pay in 2013.

Rhodes also received $149.2K in bonus, $364K in salary and $1.5K in other compensation.

Rankings

In 2013, Jason P. Rhodes' compensation ranked 2,373rd out of 12,286 executives tracked by ExecPay. In other words, Rhodes earned more than 80.7% of executives.

ClassificationRankingPercentile
All
2,373
out of 12,286
81st
Division
Manufacturing
790
out of 4,612
83rd
Major group
Chemicals And Allied Products
214
out of 1,466
85th
Industry group
Drugs
142
out of 1,160
88th
Industry
Pharmaceutical Preparations
120
out of 890
87th
Source: SEC filing on April 30, 2014.

Rhodes' colleagues

We found three more compensation records of executives who worked with Jason P. Rhodes at Epizyme in 2013.

2013

Robert Gould

Epizyme

Chief Executive Officer

2013

Robert Copeland

Epizyme

Chief Scientific Officer

2013

Eric Hedrick

Epizyme

Chief Medical Officer

In-depth

You may also like